Intuitive Surgical 株価情報 (NASDAQ: ISRG)

最新ニュース Intuitive Surgical (NASDAQ:ISRG) 株価情報

Intuitive Surgical

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

ISRG

NFLX

アメリカの株先物は金曜日の朝、低い動きを見せており、投資家の動きも慎重になっている。ウォール街は、オープニングベルの前に、The Procter &amp; Gamble Company（NYSE:PG）が1株あたり1.41ドル、225.41億ドルの売上で四半期決算を発表すると見込んでいます。これはBenzinga Proのデータより明らかになっています。Procter &amp; Gambleの株は、アフターセッションで157.14ドルに0.1％の下落となった。Intuitive Surgical Inc（NASDAQ:ISRG）は、木曜日に第1四半期の決算を予想を上回る結果を発表しました。インチュイティブ・サージカルの株はアフターセッションで3.5％上昇し、385.60ドルで取引されている。アナリストは、American Express Company（NYSE:AXP）が純利益2.95ドル、157.9億ドルの売上で四半期決算を発表すると予想しています。同社は市場がオープンする前に決算を発表します。アメリカン・エキスプレスの株はアフターセッションで、213.90ドルに1.7％下落を記録した。こちらのプレマーケットのカバレッジをチェックNetflix Inc（NASDAQ:NFLX）は第1四半期の楽観的な決算と売上の結果を発表しました。同社は第1四半期に933万人の有料会員を追加し、合計2億6960万人の会員数になりました。Netflixの株はアフターセッションで4.8％下落し、581.49ドルで取引されている。アナリストは、Schlumberger Limited（NYSE:SLB）がオープニングベルの前に1株あたり75セントの四半期利益を、86.9億ドルの売上で発表すると予想しています。SLBの株はアフターセッションで0.5％下落し、50.69ドルで取引されている。

「Netflix（ネットフリックス）、Procter＆Gamble（プロクター＆ギャンブル）」金曜日に注目すべき株式

Intuitive Surgical Inc

INTUITIVE SURGICAL ORD

Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) is a &#8220;fantastic company with an expensive stock,&#8221; <a href="https://www.benzinga.com/topic/jim-cramer">according to CNBC's Jim Cramer</a>.
On Oct. 17, Intuitive Surgical reported third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion.
During the latest edition of &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Cramer said Energy Transfer LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) <a href="https://www.benzinga.com/quote/ET/earnings">is a buy</a>.
Energy Transfer reported quarterly earnings of 32 cents per share which missed the analyst consensus estimate of 37 cents per share. The company reported quarterly sales of $20.772 billion which missed the analyst consensus estimate of $22.297 billion.
&#8220;Let it ride,&#8221; Cramer said when asked about T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>).
On Oct. 23, T-Mobile reported quarterly earnings of $2.61 per share, which beat the analyst consensus estimate of $2.41 per share.
Cramer recommended buying Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>). &#8220;I think it still works higher,&#8221; he added.
On Nov. 4, Constellation Energy reported third-quarter results and revised its FY24 adjusted EPS guidance, which is below estimates.
When asked about International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>), he said, &#8220;I think we can hold it.&#8221;
On Oct. 23, IBM reported third-quarter revenue of $14.968 billion, missing the consensus estimate of $15.07 billion, according to Benzinga Pro.
The Mad Money host said he is not recommending Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>). &#8220;I think they have a lot of companies that are up against them,&#8221; he noted.
On Nov. 11, Keybanc analyst Eric Heath maintained Snowflake with an Overweight and lowered the price target from $168 to $150.
Price Action:
<ul>
<li>Energy Transfer shares fell 1.1% to settle at $17.05 on Tuesday.</li>
<li>Intuitive Surgical shares gained 0.3% to close at $537.07.</li>
<li>T-Mobile shares rose 0.3% to close at $239.00 on Tuesday.</li>
<li>Constellation Energy shares fell 3.6% to settle at $228.70 during the session.</li>
<li>IBM shares fell 0.5% to close at $210.86 on Tuesday.</li>
<li>Snowflake shares gained 1.6% to settle at $125.46.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/41899303/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-in-q4">Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio In Q4</a></li>
</ul>
Courtesy of Intuitive Surgical

Long Ideas

Media

SNOW

TMUS

Jim Cramer Says Intuitive Surgical Is A 'Fantastic, Expensive Company'

Intuitive Surgical's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NYSE">ISRG</a>) short percent of float has risen 9.0% since its last report. The company recently reported that it has 3.85 million shares sold short, which is 1.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.74 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Intuitive Surgical Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731430819_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Intuitive Surgical has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Intuitive Surgical's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Intuitive Surgical's peer group average for short interest as a percentage of float is 4.16%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Intuitive Surgical?

Each week,&nbsp;Benzinga&#8217;s Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/top-stories/24/11/41718416/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-october-2024-where-do-tesla-nvidia-apple-d" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?</a>
Here's a look at the Benzinga Stock Whisper Index for the week of Nov. 8:
Insmed Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>): The biopharmaceutical company saw increased interest from investors over the week, which comes after the company <a href="https://investor.insmed.com/2024-10-31-Insmed-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Business-Update">reported </a>third-quarter financial results and provided a company update in late October. The company said ARIKAYCE had revenue of $93.4 million in the quarter, up 18% year-over-year. 
Insmed also said its NDA submission for Brensocatib in Bronchiectasis is on track for the fourth quarter and is expected to launch in the U.S. in mid-2025. 
H.C. Wainwright reiterated a Buy rating and $90 price target on the stock <a href="https://www.benzinga.com/quote/INSM/analyst-ratings">after the quarterly results</a>. Truist reiterated a Buy rating and raised the price target from $100 to $105. Investor interest could increase in the coming weeks with the company scheduled to participate in several conferences including ones from Guggenheim (Nov. 11), UBS Global (Nov. 12), Wolfe Research (Nov. 20) and Jefferies (Nov. 21).
Insmed shares were up over 8% in the last five trading days, as seen on the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1">Benzinga Pro chart</a> below, and are up over 140% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="506" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135456/Screenshot-234.png" alt="" class="wp-image-638350" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135456/Screenshot-234.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135456/Screenshot-234-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135456/Screenshot-234-768x389.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Applied Industrial Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>): The industrial company was one of several in the sector to see strong interest from readers, which could be related to Donald Trump winning<a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election"> the 2024 election.</a> Industrials were a top performing sector under <a href="https://www.benzinga.com/general/politics/24/11/41783357/how-did-s-p-500-sectors-perform-during-trumps-first-term-could-this-time-be-different">Trump&#8217;s previous four years</a> in the White House. 
The company also recently <a href="https://ir.applied.com/news/news-details/2024/Applied-Industrial-Technologies-Reports-Fiscal-2025-First-Quarter-Results/default.aspx">reported </a>first-quarter financial results with earnings per share of $2.36 and revenue of $1.10 billion, beating Street consensus estimates of $2.27 and $1.09 billion respectively. Applied Industrial also increased its fiscal 2025 earnings per share guidance to a range of $9.25 to $10.00, up from prior guidance of $9.20 to $9.95 and ahead of a Street estimate of $9.39. 
Analysts <a href="https://www.benzinga.com/quote/AIT/analyst-ratings">raised their price targets</a> on the stock after the quarterly results. The stock was up over 15% in the last five trading days and is up over 50% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="503" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135510/Screenshot-236.png" alt="" class="wp-image-638351" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135510/Screenshot-236.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135510/Screenshot-236-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135510/Screenshot-236-768x388.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>): The specialty grocery retailer saw strong interest from Benzinga readers during the week, which comes after <a href="https://investors.sprouts.com/news/news-details/2024/Sprouts-Farmers-Market-Inc.-Reports-Third-Quarter-2024-Results/default.aspx">recent </a>quarterly results and with shares trading at 52-week highs. The company's third-quarter earnings per share of 91 cents and revenue of $1.90 billion beat Street estimates of 76 cents per share and $1.88 billion respectively.
The company said the third quarter was exceptional and CEO Jack Sinclair highlighted "robust traffic growth." Same store sales were up 8.4% in the third quarter. The company opened nine new stores, ending the quarter with 428 stores in 23 states. 
Goldman Sachs recently <a href="https://www.benzinga.com/quote/SFM/analyst-ratings">maintained a Buy rating </a>on the stock and raised the price target from $127 to $159. Wells Fargo maintained an Equal-Weight rating on the stock and raised the price target from $90 to $130. 
The stock was up over 10% over the last five trading days, and shares are up over 190% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="503" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135528/Screenshot-237.png" alt="" class="wp-image-638353" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135528/Screenshot-237.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135528/Screenshot-237-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135528/Screenshot-237-768x388.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>): The medical devices company saw strong interest from readers over the last week, with shares trading at 52-week highs Friday. 
The company recently reported <a href="https://www.benzinga.com/news/earnings/24/10/41391471/intuitive-surgical-stock-pops-on-q3-earnings-beat-da-vinci-procedures-climb-18-regulatory-clearance">third-quarter financial results </a>with revenue of $2.04 billion beating a Street consensus estimate of $2.0 billion and earnings per share of $1.84 beating a Street consensus estimate of $1.63. Intuitive Surgical reported revenue growth of 17% year-over-year in the quarter, with worldwide da Vinci procedures up 18% year-over-year. 
The company also placed 379 da Vinci systems in the quarter, up from 312 in the prior quarter. There are 9,539 installed da Vinci surgical systems as of the end of the quarter. Intuitive obtained regulatory clearance for the da Vinci 5 surgical system in South Korea in October. 
The earnings report saw several<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406234/intuitive-surgical-posts-q3-earnings-beat-these-analysts-raise-forecasts-on-dv5-upt"> analysts raise their price targets </a>on the stock. Analysts see the company's updated da Vinci 5 system, which can be used for more types of surgeries as a growth catalyst moving forward. Shares of Intuitive Surgical were up around six percent in the last five days and are up over 60% year-to-date.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135542/Screenshot-238.png" alt="" class="wp-image-638354" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135542/Screenshot-238.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135542/Screenshot-238-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135542/Screenshot-238-768x387.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Mueller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>): The industrials company was another in the sector that saw increased interest and a soaring stock price, potential from Trump's 2024 election win. The company recently <a href="https://ir.muellerindustries.com/news/press-releases/detail/178/mueller-industries-inc-reports-third-quarter-2024-earnings">reported </a>third-quarter net sales of $997.8 million, beating a Street consensus estimate of $936.0 million and quarterly earnings per share of $1.48, which beat a Street estimate of $1.32. Mueller Industries said the revenue growth came from recently acquired businesses and higher copper prices in the quarter.
"We anticipated that declining interest rates and moderating inflation, combined with the resolution of election related uncertainty, will create a more stable and favorable environment for us," Mueller CEO Greg Christopher said.
The stock was up 13% over the last five days and is up over 100% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="508" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135559/Screenshot-240.png" alt="" class="wp-image-638355" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135559/Screenshot-240.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135559/Screenshot-240-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135559/Screenshot-240-768x392.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Stay tuned for next week&#8217;s report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/exclusives/24/10/41405659/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">October 18</a></li>
<li><a href="https://www.benzinga.com/real-estate/reit/24/10/41549488/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">October 25</a></li>
<li><a href="https://www.benzinga.com/exclusives/24/11/41693907/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">November 1</a></li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/24/11/41779731/trump-victory-sends-bank-stocks-higher-leading-s-p-500-on-regulatory-hopes">Trump Victory Sends Bank Stocks Higher, Leading S&amp;P 500 On Regulatory Hopes</a></li>
</ul>
Photo: Benzinga

Exclusives

INSM

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

On CNBC's &#8220;Mad Money Lightning Round,&#8221; <a href="https://www.benzinga.com/topic/jim-cramer">Jim Cramer recommended</a> buying Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
On Oct. 17, Intuitive Surgical reported third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion. The robotic-assisted surgery company reported third-quarter adjusted earnings of $1.84 per share, beating analyst estimates of $1.63 per share, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Kimco Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIM#NYSE">KIM</a>) is a &#8220;great operator, just own it right through,&#8221; he said.
On Oct. 1, Kimco Realty announced the acquisition of Waterford Lakes Town Center, a 976,000-square-foot signature asset spanning 79 acres in Orlando, Florida, for $322 million, including the assumption of a $164 million mortgage.
&#8220;That is such a hard story to understand,&#8221; Cramer said when asked about Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>).
On Oct. 28, Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $71 to $72.
The &#8220;Mad Money&#8221; host said CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) is a buy.
On Oct. 22, CrowdStrike partnered with Fortinet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) to enhance endpoint and firewall protection by integrating its AI-native security from the Falcon platform with FortiGate next-generation firewalls (NGFW).
Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) is a &#8220;high speculative&#8221; stock, he said.
On Oct. 24, Keybanc analyst Michael Leshock maintained Rocket Lab with an Overweight and raised the price target from $11 to $12.
Price Action:
<ul>
<li>Intuitive Surgical shares gained 1.1% to settle at $516.31 on Tuesday.</li>
<li>Kimco shares declined 0.9% to close at $23.67 on Tuesday.</li>
<li>Nutanix shares rose 1.3% to settle at $64.97 during the session.</li>
<li>CrowdStrike shares gained 3.2% to settle at $310.94 on Tuesday.</li>
<li>Rocket Lab gained 1.9% to settle at $11.47 on Tuesday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41599928/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-for-october">Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio For October</a></li>
</ul>
Photo: s_bukley/Shutterstock.com

CRWD

FTNT

NTNX

RKLB

Jim Cramer Says Buy CrowdStrike Stock, Calls This Aerospace Manufacturer A 'High Speculative' Stock

AI-themed exchange-traded funds (ETFs) are witnessing a significant surge as asset managers capitalize on the growing enthusiasm surrounding <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence</a>. This year, over one-third of the two dozen AI-focused ETFs were launched, according to Morningstar.
What Happened: In the past week alone, three new ETFs have entered the AI sector, including one that was rebranded to specifically focus on artificial intelligence, Reuters reported on Monday. The total assets of AI ETFs have now reached $4.5 billion, approaching the $5.5 billion held by nuclear power-themed ETFs and surpassing the $1.37 billion in the cannabis sector.
Daniel Sotiroff, a senior analyst at Morningstar, remarked on the trend, stating, &#8220;I&#8217;m not surprised their ranks are multiplying.&#8221; 
He emphasized that the industry&#8217;s rapid pace attracts investors eager for quick returns, according to the report.
See Also: <a href="https://www.benzinga.com/markets/equities/24/10/41560703/november-interest-rate-cut-almost-a-done-deal-as-blackout-begins-10-stocks-surging-the-most-sinc?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">November Interest Rate Cut Almost A Done Deal As Blackout Begins: 10 Stocks Surging The Most Since Fed&#8217;s Last Decision</a>
As per Benzinga Pro data, here are how some of the AI-based ETFs performed over the past year:
Global X Robotics and Artificial Intelligence ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOTZ#NASDAQ">BOTZ</a>): BOTZ, currently with net assets worth $2.51 billion and NAV of $31.59, climbed 40.39%. Its top AI-related holdings include Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and biotech firm Intuitive Surgical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
Global X Artificial Intelligence &amp; Technology ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIQ#NASDAQ">AIQ</a>): AIQ, which has $2.27 billion in net assets and $37.36 NAV, increased by 43.64%. Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), Cisco Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), and Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) are some of its top AI-related holdings.
iShares US Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYW#NYSE">IYW</a>): IYW gained 50.72% in the past year. The ETF has an NAV of $155.42 and $19.24 billion in net assets. It also gives exposure to tech stocks like Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Nvidia, Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) which have witnessed stellar growth, thanks to AI buzz.
Fidelity MSCI Information Technology Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTEC#NYSE">FTEC</a>): The ETF witnessed a 48.55% growth while exposing to stocks like Apple, Microsoft, Nvidia, Alphabet and Broadcom. It holds $12.05 billion in net assets. 
Why It Matters: The surge in AI-themed ETFs is part of a broader trend driven by the increasing demand for artificial intelligence technologies. Recently, Nvidia briefly surpassed Apple to become the <a href="https://www.benzinga.com/markets/equities/24/10/41551461/nvidia-overtakes-apple-as-worlds-most-valuable-company-again">world&#8217;s most valuable company</a>, fueled by the demand for its AI supercomputing chips. This highlights the growing importance of AI in the tech sector.
Moreover, the <a href="https://www.benzinga.com/news/24/10/41351070/imf-warns-ai-in-stock-trading-can-boost-efficiency-but-warns-of-increased-market-volatility">International Monetary Fund</a> (IMF) has noted AI&#8217;s potential to enhance market efficiency but warns of increased volatility and cyber threats. The IMF&#8217;s Global Financial Stability Report suggests that AI-driven trading could revolutionize markets, although its adoption remains limited. The report also cautions about the potential shift of investments to less regulated nonbank financial intermediaries, complicating market oversight.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41517027/five-us-banks-face-billions-in-losses-as-silvers-price-spike-hits-short-sellers-hard-report?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Five US Banks Face Billions In Losses As Silver&#8217;s Price Spike Hits Short Sellers Hard: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Unsplash

Sector ETFs

ETFs

General

AAPL

AVGO

BOTZ

CSCO

FTEC

iShares Dow Jones US Technology Sector Index Fund

MSFT

NVDA

ORCL

More Than A Third Of AI-Based ETFs Were Launched In 2024, Focusing On Nvidia, Microsoft, Apple And Meta, Among Others: Here's How Some Of Them Have Performed This Year So Far

Financial giants have made a conspicuous bearish move on Intuitive Surgical. Our analysis of options history for Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) revealed 8 unusual trades.
Delving into the details, we found 12% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $426,801, and 6 were calls, valued at $285,918.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $350.0 to $520.0 for Intuitive Surgical over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Intuitive Surgical options trades today is 147.75 with a total volume of 588.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Intuitive Surgical's big money trades within a strike price range of $350.0 to $520.0 over the last 30 days.
<h3>Intuitive Surgical 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729888259_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.3</td>
<td>$7.9</td>
<td>$7.9</td>
<td>$465.00</td>
<td>$253.5K</td>
<td style="text-align: right;">94</td>
<td style="text-align: right;">322</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$47.1</td>
<td>$46.7</td>
<td>$46.9</td>
<td>$500.00</td>
<td>$173.2K</td>
<td style="text-align: right;">57</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$168.7</td>
<td>$167.6</td>
<td>$168.6</td>
<td>$350.00</td>
<td>$67.4K</td>
<td style="text-align: right;">348</td>
<td style="text-align: right;">8</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$37.3</td>
<td>$36.7</td>
<td>$37.0</td>
<td>$520.00</td>
<td>$55.5K</td>
<td style="text-align: right;">92</td>
<td style="text-align: right;">15</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$170.5</td>
<td>$168.6</td>
<td>$168.6</td>
<td>$350.00</td>
<td>$50.5K</td>
<td style="text-align: right;">348</td>
<td style="text-align: right;">3</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
<h3>Present Market Standing of Intuitive Surgical</h3>
<ul>
<li>With a volume of 979,283, the price of ISRG is down -0.07% at $511.27. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 88 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Surgical</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $543.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $525. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $570. 
&#x2A; Consistent in their evaluation, an analyst from Baird keeps a Outperform rating on Intuitive Surgical with a target price of $565. 
&#x2A; An analyst from Raymond James persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $540. 
&#x2A; An analyst from BTIG has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $518. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Market Whales and Their Recent Bets on ISRG Options

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 20 years by 20.19% on an annualized basis producing an average annual return of 28.68%. Currently, Intuitive Surgical has a market capitalization of $182.11 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 20 years ago, it would be worth $15,521.76 today based on a price of $511.30 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729778412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today

In the current market session, Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) stock price is at $515.80, after a 0.59% decrease. However, over the past month, the company's stock spiked by 6.48%, and in the past year, by 93.47%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1729615537_0.png" alt="Past Year Chart" />

<h3>Intuitive Surgical P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Intuitive Surgical has a lower P/E than the aggregate P/E of 263.65 of the Health Care Equipment &amp; Supplies industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1729615537_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: Intuitive Surgical

Whales with a lot of money to spend have taken a noticeably bearish stance on Intuitive Surgical.
Looking at options history for Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) we detected 21 trades.
If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish expectations and 66% with bearish.
From the overall spotted trades, 11 are puts, for a total amount of $884,979 and 10, calls, for a total amount of $2,075,713.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $250.0 to $620.0 for Intuitive Surgical over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale activity within a strike price range from $250.0 to $620.0 in the last 30 days. 
<h3>Intuitive Surgical Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729531821_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$63.9</td>
<td>$63.2</td>
<td>$63.2</td>
<td>$470.00</td>
<td>$1.2M</td>
<td style="text-align: right;">313</td>
<td style="text-align: right;">270</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$64.0</td>
<td>$63.2</td>
<td>$63.2</td>
<td>$470.00</td>
<td>$316.0K</td>
<td style="text-align: right;">313</td>
<td style="text-align: right;">70</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$97.1</td>
<td>$94.0</td>
<td>$97.1</td>
<td>$570.00</td>
<td>$184.4K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">21</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$101.9</td>
<td>$97.4</td>
<td>$101.9</td>
<td>$580.00</td>
<td>$142.6K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">21</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$44.4</td>
<td>$44.3</td>
<td>$44.32</td>
<td>$500.00</td>
<td>$132.9K</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">54</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Intuitive Surgical</h3>
<ul>
<li>With a volume of 682,367, the price of ISRG is down -0.47% at $518.69. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 92 days.</li>
</ul>
<h3>What Analysts Are Saying About Intuitive Surgical</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $540.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Intuitive Surgical, maintaining a target price of $549. 
&#x2A; An analyst from BTIG has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $535. 
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $538. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $555. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $525. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Smart Money Is Betting Big In ISRG Options

This week, the Vanguard S&amp;P 500 ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NASDAQ">VOO</a>) saw a roughly 0.7% gain, reflecting a broadly positive sentiment on Wall Street driven by a combination of upbeat earnings and <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41386234/strong-september-retail-sales-put-feds-next-move-in-doubt-interest-rate-cuts-are-">macroeconomic factors</a>. 
VOO, which is designed to track the performance of the S&amp;P 500, benefits from movements in its underlying components, making it a key barometer for the overall U.S. stock market.
What&#8217;s Happening: One of the major drivers for VOO's upward movement was a strong start to earnings season that boosted investor confidence. Notably, Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) surged 10% <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406623/netflix-should-continue-to-outperform-6-analysts-on-streaming-stocks-q3-earnings">after reporting an earnings beat</a>.
As Netflix is a significant part of the S&amp;P 500, its performance positively influenced VOO's price. Other companies, such as Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), which jumped over 9% on earnings, further contributed to the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406234/intuitive-surgical-posts-q3-earnings-beat-these-analysts-raise-forecasts-on-dv5-upt">bullish market sentiment</a>.
On Thursday, semiconductor stocks fueled a major push for the S&amp;P 500, as <a href="https://www.benzinga.com/news/earnings/24/10/41373163/nvidia-supplier-tsmc-reports-q3-revenue-earnings-beat-amid-rising-demand-for-ai-chips">strong earnings</a> from Taiwan Semiconductor Mfg. Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSMC#NYSE">TSMC</a>) invigorated investor confidence in the tech sector.
Read Also: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/10/41407647/spy-reaches-600-billion-in-assets-oldest-us-etf-hits-milestone-as-all-time-highs-conti">SPY Reaches $600 Billion In Assets: Oldest US ETF Hits Milestone As All-Time Highs Continue</a>
This semiconductor rally played a pivotal role in driving the S&amp;P 500 higher, and by extension, VOO, as technology remains one of the largest sectors in the index.
What Else: Gold miners saw strong momentum as gold prices reached new record highs, with the VanEck Gold Miners ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NASDAQ">GDX</a>) climbing nearly 4% Friday.
While VOO's exposure to gold miners is limited, the broader gains in commodity-related sectors helped balance weaker performances in sectors like energy.
Macroeconomic data released on Thursday also played a role in sustaining the market's positive momentum. September retail sales exceeded expectations, signaling robust consumer spending, while jobless claims fell, underscoring labor market strength. 
Although the positive data slightly diminished hopes for Federal Reserve rate cuts in November, it reinforced the view of economic resilience, which supported investor sentiment across equity markets. VOO, as a broad-market ETF, was a key beneficiary of this optimism.
Read Also: <a href="https://www.benzinga.com/exclusives/24/10/41405659/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a>

Market Vectors ETF Trust Market Vectors Gold Miners

TSMC

What's Going On With Vanguard S&P 500 ETF (VOO) This Week?

Wall Street was in positive territory in Friday midday trading, buoyed by upbeat quarterly earnings reports that kept <a href="https://www.benzinga.com/markets">investor sentiment bullish.</a>
Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) surged 10% to fresh record highs after delivering a strong earnings beat. The tech-heavy Nasdaq 100 rose 0.8%, pushing its weekly performance into positive territory for the sixth consecutive week.
The S&amp;P 500 and Dow also edged higher, both on track for the sixth straight week of gains, with the Dow flirting with all-time highs.
Gold miners led industry performance as gold prices hit new record levels above $2,700 per ounce. The VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) soared over 4%, hitting the highest level in over four years. Friday is poised to mark the fourth straight session of gains for both gold and silver, with silver jumping over 3%, heading for its best day since late September.
West Texas Intermediate (WTI) crude prices tumbled more than 2%, slipping below the $70-per-barrel mark. WTI is down over 8% for the week, on pace for its worst weekly decline since January.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) climbed 2.8% to above $68,800.
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % change</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,352.25</td>
<td>0.8%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,870.75</td>
<td>0.5%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,300.82</td>
<td>0.1%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,279.45</td>
<td>-0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:55 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.5% to $585.12.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% higher to $433.01.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.8% to $495.21.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) stalled at $226.03.</li>
<li>The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) outperformed, up 0.9%. The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.6%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul>
<li>Stocks moving in reaction to earnings reports were Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), up over 9%, Crown Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>), up over 4%, Western Alliance Bancorporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>), down 6%, American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), down 2.4%, Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) down 0.4%, Schlumberger N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) down 3.3%, Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>), down 1.7%, Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), down 1% and Comerica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>), up 4%. </li>
<li>Lamb Weston Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) soared 10% following a report indicating that activist investor&nbsp;Jana Partners&nbsp;has built a 5% stake in the company.</li>
<li>CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) fell over 6% after the company replaced its CEO and cut its third-quarter outlook.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406623/netflix-should-continue-to-outperform-6-analysts-on-streaming-stocks-q3-earnings">Netflix &#8216;Should Continue To Outperform&#8217;: 6 Analysts On Streaming Stock&#8217;s Q3 Earnings</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Equities

Broad U.S. Equity ETFs

Treasuries

Econ #s

Tech

$BTC

ALLY

SPDR Dow Jones Industrial Average ETF Trust

FITB

Stocks Rise, Netflix Soars To Record Highs, Oil Falls Below $70, Gold Miners Rally: What's Driving Markets Friday?

Evercore ISI Group analyst Vijay Kumar maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a In-Line and raises the price target from $475 to $490.

Price Target

Analyst Ratings

Evercore ISI Group Maintains In-Line on Intuitive Surgical, Raises Price Target to $490

Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) Thursday reported <a href="https://www.benzinga.com/news/24/10/41399062/why-intuitive-surgical-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket">upbeat earnings for its third quarter</a>.
The company reported its results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<ul>
<li>RBC Capital Markets <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/606ed90d9e63ea0001ef8211/shagun-singh">analyst Shagun Singh</a> reiterated an Outperform rating, while raising the price target from $525 to $555.</li>
<li>Stifel analyst Rick Wise maintained a Buy rating, while lifting the price target from $475 to $525.</li>
<li>Goldman Sachs <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/66585980a3067c00012c48c0/david-roman">analyst David Roman</a> reaffirmed a Buy rating, while raising the price target from $583 to $604.</li>
<li>Piper Sandler <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6010072ea6fe6f000120d9a0/anthony-elian">analyst Adam Maeder</a> maintained an Overweight rating, while lifting the price target from $495 to $538.</li>
<li>Truist Securities <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/613f4c11b4035700018daeca/brandon-king">analyst Richard Newitter</a> reiterated a Buy rating and price target of $570.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
RBC Capital Markets: Intuitive Surgical reported its third-quarter sales 2% higher than estimates. This was driven by robust procedure volume growth and gross system placements, Singh said in a note. The company also reported a 12% earnings beat on "revenue drop-through and strong margins," he added.
Management raised the low end of their guidance for procedure volumes by 50 basis points (bps) to 16%-17%, with the upper end assuming that bariatric procedures stabilize at the current quarter's rates and that headwinds in Korea and China do not worsen, the analyst stated. Management also lowered their projection for operating expense growth by 50 bps at the midpoint, he added.
Stifel: Intuitive Surgical achieved "one of the fastest installed base growth rates in years, at 15.1%," Wise said. The company is well-positioned to approach 10,000 robots installed by the end of 2024.
The midpoint of the new guidance range implies around 2.6 million procedures in 2024, the analyst stated. "Just seven months following the US da Vinci 5 (dv5) approval, Intuitive is already generating meaningful post-launch growth momentum," which suggests the potential for acceleration in 2025, he further wrote.
Goldman Sachs: Intuitive Surgical reported third-quarter revenues of $2.04 billion. That&#8217;s up 17% year-on-year and ahead of consensus of $2 billion. "Against strong YTD performance, 3Q results underscore sustained momentum in the top-line and, as importantly, the significant earnings leverage and upside in the model," Roman said
The company has "multiple layers of growth," including the continued rollout of dv5 until mid-2025, uptake of the new SP platform and continued adoption of the ION diagnostics system, the analyst stated. "Importantly, with Intuitive's consistent investment in the robotic surgery ecosystem and differentiated technology, we are increasingly confident in the company further extending its competitive advantage," he further wrote.
Piper Sandler: &#8220;We were also encouraged to see another strong placement quarter for DV5 (110 systems in Q3) and hear that ISRG is tracking towards a broad launch in mid-2025," Maeder wrote in a note. Management indicated that physician feedback of the system had been strong, he added.
Leverage was another "bright spot in the quarter," as the company reported adjusted operating margins of 37.0%, well ahead of "our 33.3% bogey," the analyst stated. Although estimates have been raised, there is "ample opportunity for upside to play out going forward," he further wrote.
Truist Securities: Intuitive Surgical delivered a massive beat on DV5, at 110 versus analyst estimate of 78, Newitter said. The upside delivered by DV5 in its soft launch is "particularly encouraging." It gives greater confidence in further estimate upside and growth acceleration into 2025, when the full launch in planned, he added.
Intuitive Surgical should be able to sustain its "already substantial lead" in a large and underpenetrated robotic opportunity.
ISRG Price Action: Shares of Intuitive Surgical had risen by 8.63% to $514.59 at the time of publication on Friday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41404035/autoliv-posts-strong-sales-joins-united-states-cellular-netflix-intuitive-surgical-and-other-big-sto">Autoliv Joins United States Cellular, Netflix, Intuitive Surgical And Other Big Stocks Moving Higher On Friday</a></li>
</ul>
Courtesy of Intuitive Surgical

Earnings Beats

Reiteration

Movers

Intuitive Surgical Posts Q3 Earnings Beat, These Analysts Raise Forecasts On DV5 Uptake

BTIG analyst Ryan Zimmerman maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and raises the price target from $518 to $535.

BTIG Maintains Buy on Intuitive Surgical, Raises Price Target to $535

U.S. stocks were mixed , with the Nasdaq Composite gaining around 100 points on Friday.
Shares of Autoliv, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41403377/autoliv-surges-despite-mixed-q3-results-chinese-market-mix-drags-performance">third-quarter sales results</a>.
The company reported third-quarter adjusted earnings per share of $1.84, missing the analyst consensus of $1.95. Quarterly revenues of $2.56 billion topped the street view of $2.53 billion.
Autoliv shares jumped 5.5% to $99.13 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) gained 19% to $18.73. Amazon Web Services recently announced plans to invest over $500 million in nuclear power.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) gained 18.7% to $22.25.</li>
<li>Telephone and Data Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) climbed 18% to $29.80.</li>
<li>Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) gained 14% to $6.01. Peloton Interactive will release its first quarter fiscal 2025 results before the opening bell on Thursday, Oct. 31.</li>
<li>Uxin Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UXIN#NASDAQ">UXIN</a>) jumped 13.1% to $6.47. Uxin recently announced a strategic partnership with Wuhan City Economic &amp; Technological Development Zone.</li>
<li>United States Cellular Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) gained 13.1% to $66.39. after the company announced the sale of a portion of its retained spectrum licenses to Verizon for $1 billion.</li>
<li>XCHG Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) gained 12.7% to $22.08.</li>
<li>ClearPoint Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) surged 11.2% to $13.42. ClearPoint Neuro will release financial results for its 2024 third quarter on Thursday, Nov. 7, after the market close.</li>
<li>Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) gained 10.5% to $759.82 following upbeat quarterly results.</li>
<li>IonQ, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NASDAQ">IONQ</a>) surged 8.8% to $13.61. IonQ will report third quarter financial results on Nov. 6.</li>
<li>Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) gained 8.8% to $515.57 following better-than-expected third-quarter financial results.</li>
<li>Nokia Oyj (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) gained 6.3% to $4.6150. Nokia recently company reported worse-than-expected third-quarter EPS and sales.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

CLPT

IONQ

OKLO

PTON

UXIN

Autoliv Posts Strong Sales, Joins United States Cellular, Netflix, Intuitive Surgical And Other Big Stocks Moving Higher On Friday

Piper Sandler analyst Adam Maeder reiterates Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Overweight and raises the price target from $495 to $538.

Piper Sandler Reiterates Overweight on Intuitive Surgical, Raises Price Target to $538

Stifel analyst Rick Wise maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and raises the price target from $475 to $525.

Stifel Maintains Buy on Intuitive Surgical, Raises Price Target to $525

Wells Fargo analyst Larry Biegelsen maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Overweight and raises the price target from $466 to $549.

Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $549

RBC Capital analyst Shagun Singh maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Outperform and raises the price target from $525 to $555.

RBC Capital Maintains Outperform on Intuitive Surgical, Raises Price Target to $555

SOBR: 272% &#x7C; <a href="https://www.benzinga.com//node/41391850">SOBR Safe shares are trading higher after the company announced it filed a form RW and will not pursue a public offering at this time.</a>
&nbsp;
DRUG: 73% &#x7C; <a href="https://www.benzinga.com//node/41400342">Bright Minds Biosciences shares are trading higher. The company announced a $35 million non-brokered private placement.</a>
&nbsp;
ISRG: 9% &#x7C; <a href="https://www.benzinga.com//node/41399053">Intuitive Surgical shares are trading higher following better-than-expected Q3 financial results.</a>
&nbsp;
&nbsp;

DRUG

SOBR

Market-Moving News for October 18th

Healthcare Investing Finding Growth Beyond Pharmaceuticals

With advanced technologies like AI and machine learning, the growing prevalence of robots, and rapid demand, the AI-driven robotics industry is flourishing. Thus, fundamentally sound AI-powered robotics stocks Intuitive Surgical (ISRG), Rockwell Automation (ROK), and iRobot (IRBT) could be suitable investments. Keep reading... The AI-powered robotics industry has proliferated and is poised for further expansion in the upcoming years, fueled by the demand surge for automation and precision. Also, the ongoing labor shortage and cost reduction strategies are leaning more and more industries toward the adoption of AI robots.
Against this backdrop, investors could consider investing in quality AI-powered robotics stocks Intuitive Surgical, Inc. (<a href="https://stocknews.com/stock/ISRG/">ISRG</a>), Rockwell Automation, Inc. (<a href="https://stocknews.com/stock/ROK/">ROK</a>), and iRobot Corporation (<a href="https://stocknews.com/stock/IRBT/">IRBT</a>) for the next industrial revolution.
Robotics is no longer just a vision but has become a reality and is transforming the operations and lives of today's generations. The robotics market is marking strong impacts in many essential end-user industries, including the medical field and industrial machinery, and even revolutionizing the home improvement market. This growth rally is to continue in the coming period as well.
Last year, the number of operational robots across the world evidenced a rapid surge and hit a new record, reaching 3.9 million units, as per the <a href="https://ifr.org/ifr-press-releases/news/top-5-robot-trends-2024">International Federation of Robotics</a>. Compelling trends like AI and machine learning, Cobots in new applications, mobile manipulators, digital twin technology, and humanoid robots substantially contribute to the market growth.
With this, the global AI robotics market is expected to hit around $17.03 billion in 2024, where the United States will emerge as the largest market with $5.64 billion in the same year. The global market is also expected to grow at a <a href="https://www.statista.com/outlook/tmo/artificial-intelligence/ai-robotics/worldwide">CAGR of 24.8%</a>, resulting in a market volume of $64.35 billion by 2030.
The <a href="https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-robots-market-120550497.html">Artificial Intelligence robots</a> market is rapidly growing with continuous advancements in AI technologies, increasing adoption, and growing demand for automation. Also, the expanding contribution of AI robotics through increased production efficiency, precision in processes, reduced operational costs, and assistance are playing pivotal roles in the adoption.
Given the industry's bright prospects, investors could consider fundamentally strong robotics stocks such as ISRG, ROK, and IRBT.
Let's discuss the fundamentals of these stocks in detail:
Intuitive Surgical, Inc. (<a href="https://stocknews.com/stock/ISRG/">ISRG</a>)
ISRG develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care internationally. It provides the da Vinci Surgical System, allowing complex surgery using a minimally invasive approach, and the Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures.
On June 5, ISRG received FDA approval for a labeling revision for its updated da Vinci X and Xi label, confirming their use in radical prostatectomy. The approval is backed by real-world data, which shows that robotic-assisted surgeries offer long-term survival rates similar to traditional methods.
During the third quarter ended September 30, 2024, ISRG's total revenue increased 16.9% year-over-year to $2.04 billion. Its non-GAAP <a href="https://www.investopedia.com/terms/g/grossprofit.asp#:~:text=Gross%20profit%2C%20or%20gross%20income,fluctuate%20compared%20to%20production%20output.">gross profit</a> grew 17.3% from the year-ago value to $1.41 billion. The company's non-GAAP income from operations of $754.90 million indicates a 21% growth from the prior-year period.
In addition, non-GAAP net income attributable to ISRG stood at $669.10 million and $1.84 per share, up 27.7% and 26% year-over-year, respectively.
Analysts expect ISRG's revenue for the fourth quarter (ending December 2024) to increase 13.9% year-over-year to $2.20 billion, and its EPS for the same quarter is expected to grow 9.4% year-over-year to $1.75. Furthermore, the company has topped the consensus revenue and EPS estimates in each of the trailing four quarters.
Shares of ISRG have gained 39.9% over the past six months and 89.2% over the past year to close the last trading session at $521.15.
ISRG's bright prospects are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
ISRG has an A grade for Sentiment. It is ranked #59 out of 136 stocks in the <a href="https://stocknews.com/category/medical-devices-equipment/">Medical – Devices &amp; Equipment</a> industry.
To check other POWR Ratings of ISRG for Quality, Value, Momentum, Growth, and Stability, <a href="https://stocknews.com/stock/ISRG/">click here</a>.
Rockwell Automation, Inc. (<a href="https://stocknews.com/stock/ROK/">ROK</a>)
ROK provides industrial automation and digital transformation solutions internationally. The company operates in three segments, Intelligent Devices; Software &amp; Control; and Lifecycle Services.
On September 10, ROK launched Logix SIS, a cutting-edge safety instrumented system (SIS) designed to address the evolving needs of modern industrial environments. The introduction expands the company's industry-leading safety technology portfolio.
Logix SIS offers a modern and integrated safety solution, providing both SIL 2 and SIL 3 certifications for enhanced process and hybrid safety.
On July 25, ROK and Cisco, a worldwide leader in networking and security, signed a Memorandum of Understanding (MOU) to collaborate and propel the digital transformation of the industrial market in the Asia Pacific, Japan, and Greater China region.
The combined expertise empowers manufacturers to streamline their operations, boost productivity, improve sustainability, and fortify the security of their industrial networks.
ROK posted sales of $2.05 billion for the third quarter that ended June 30, 2024, of which its Lifecycle Services sales increased 11.8% year-over-year to $581.20 million. The company's adjusted net income and adjusted EPS totaled $311.30 million and $2.71 for the quarter, respectively.
The company updated its fiscal year 2024 outlook for adjusted EPS to $9.60. Also, it continues to expect inorganic sales growth of 15% for the year.
Analysts expect ROK's revenue and EPS for the second quarter (ending March 2025) to grow 1.7% and 2.2% year-over-year to $2.16 billion and $2.56, respectively. Moreover, the company surpassed the consensus EPS and revenue estimates in three of the trailing four quarters.
Over the past month, the stock has surged 3.3% to close the last trading session at $272.82.
ROK's POWR Ratings reflect its robust outlook. ROK has a B grade for Quality. It is ranked #61 among 79 stocks within the A-rated <a href="https://stocknews.com/category/industrial-machinery/">Industrial - Machinery</a> industry.
To see the other ratings of ROK for Growth, Value, Stability, Sentiment, and Momentum, <a href="https://stocknews.com/stock/ROK/">click here</a>.
iRobot Corporation (<a href="https://stocknews.com/stock/IRBT/">IRBT</a>)
IRBT designs, builds, and sells robots and home innovation products internationally. The company provides floor care products, Roomba accessories and consumables, the Braava family of automatic floor mopping robots, and Braava accessories and consumables.
On July 23, IRBT unveiled the Roomba Combo 10 Max Robot with the AutoWash&#x2122; Dock, its most advanced vacuum and mop. The 2-in-1 device independently handles refilling, recharging, washing, and self-cleaning. Powered by iRobot OS, the innovative has Enhanced Dirt Detect&#x2122; Technology allowing identification and concentration on heavy dirt areas.
For the second quarter that ended June 29, 2024, IRBT reported revenue of $166.36 million. The company's non-GAAP gross profit came in at $27.74 million for the quarter. Furthermore, the company's cash and cash equivalents and total assets stood at $108.51 million and $585.94 million as of June 29, 2024.
Analysts expect IRBT's revenue for the third quarter (ended September 2024) to grow 17.3% year-over-year to $218.41 million. For the fiscal year 2025, the company's revenue is expected to increase 3.2% year-over-year to $818.02 million.
Over the past month, IRBT's stock has surged 7.1% and 9.7% over the past six months to close the last trading session at $7.95.
IRBT's sound fundamentals are reflected in its POWR Ratings. IRBT has a B grade for Momentum. It is ranked #52 among the 57 stocks within the B-rated <a href="https://stocknews.com/category/home-improvement-goods/">Home Improvement &amp; Goods</a> industry.
To see the other ratings of IRBT for Growth, Quality, Value, Stability, and Sentiment, <a href="https://stocknews.com/stock/IRBT/">click here</a>.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
ISRG shares were unchanged in after-hours trading Monday. Year-to-date, ISRG has gained 53.80%, versus a 23.95% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/isrg-rok-irbt-3-ai-powered-robotics-stocks-for-the-next-industrial-revolution/>3 AI-Powered Robotics Stocks for the Next Industrial Revolution</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 AI-Powered Robotics Stocks for the Next Industrial Revolution

As healthcare rapidly advances, AI-driven technologies present compelling investment opportunities. Hence, investors might find promising potential in fundamentally solid healthcare stocks like Intuitive Surgical (ISRG), Illumina (ILMN), and Teladoc Health (TDOC). Keep reading... As digital transformation accelerates in healthcare, the adoption of artificial intelligence is on the rise, driven by advanced technologies, clinical research innovations, and demand for personalized care.
Leading the charge in AI-driven healthcare innovation, IIntuitive Surgical, Inc. (<a href="https://stocknews.com/stock/ISRG/">ISRG</a>), Illumina, Inc. (<a href="https://stocknews.com/stock/ILMN/">ILMN</a>), and Teladoc Health, Inc. (<a href="https://stocknews.com/stock/TDOC/">TDOC</a>) are revolutionizing the industry with cutting-edge technologies that promise to reshape patient care and medical precision. So investors could scoop up the stocks to reap the benefits.
The healthcare industry's growing reliance on digital technology is accelerating global adoption of AI, enhancing patient care and reducing costs. This growth is fueled by factors such as rising chronic illnesses, an aging population, and the demand for personalized medicine. The global AI in healthcare market is projected to grow to approximately $355.78 billion by 2032, indicating a robust <a href="https://www.towardshealthcare.com/insights/ai-in-healthcare-market#:~:text=The%20global%20AI%20in%20healthcare%20market%20is%20estimated,clinical%20research%20and%20rising%20demand%20for%20customized%20healthcare.">CAGR of 37.7%</a>.
Additionally, AI and machine learning are being integrated to improve patient outcomes and enable early diagnosis, especially for neurodegenerative diseases. Advances in AI processing power have further propelled the use of algorithms in healthcare.
Considering these conducive trends, let's examine the healthcare stocks in detail.
Intuitive Surgical, Inc. (<a href="https://stocknews.com/stock/ISRG/">ISRG</a>)
ISRG develops innovative minimally invasive surgical and diagnostic systems, including the da Vinci Surgical System and Ion endoluminal system. Supporting global healthcare providers, the company offers advanced instrumentation, comprehensive training, and robust service infrastructure for enhanced surgical performance and patient care.
During the fiscal third quarter that ended September 30, 2024, ISRG's total revenue increased 17% year-over-year to $2.04 billion. In addition, the company's non-GAAP net income and EPS came in at $669.10 million and $1.84 per share, up 27.7% and 26% over the prior-year quarter, respectively.
Analysts expect ISRG's EPS and revenue for the fourth quarter, ending in December 2024, to increase 9.5% and 14.1% year-over-year to $1.75 and $2.20 billion, respectively. It surpassed the Street EPS and revenue estimates in each of the trailing four quarters, which is promising.
Over the past year, the stock has gained 84.1% to close the last trading session at $507.42. It soared 51.3% year-to-date.
ISRG's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect its robust outlook. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.
ISRG has an A grade in Sentiment. It is ranked #72 out of 138 stocks in the <a href="https://stocknews.com/category/medical-devices-equipment/">Medical - Devices &amp; Equipment</a> industry.
Beyond what we have stated above, we have also given ISRG grades for Growth, Stability, Value, Momentum, and Quality. Get all the ISRG's ratings <a href="https://stocknews.com/stock/ISRG/ratings/">here</a>.
Illumina, Inc. (<a href="https://stocknews.com/stock/ILMN/">ILMN</a>)
ILMN delivers advanced sequencing and array-based solutions for genetic and genomic analysis worldwide. Through its Core Illumina and GRAIL segments, it offers a range of instruments, consumables, and services, including whole-genome and targeted sequencing, noninvasive prenatal testing, and the Galleri multi-cancer early detection test.
On August 27, 2024, ILMN received FDA approval for its TruSight&#x2122; Oncology (TSO) Comprehensive test, along with companion diagnostics for targeted therapies. This test analyzes over 500 genes to identify biomarkers in solid tumors, potentially benefiting patients with NTRK gene fusions and RET fusion-positive NSCLC.
In the fiscal third quarter ended on September 29, 2024, ILMN's total revenues amounted to $1.08 billion. Its non-GAAP <a href="https://www.investopedia.com/terms/o/operatingmargin.asp">operating margin</a> went up 22.6% from the year-ago value of 8.3%. Moreover, its EPS stood at $4.42 compared to a loss of $4.77 in the prior-year quarter.
Street expects ILMN's EPS for the fourth quarter of 2024, ending on December 31, 2024, to increase 561.6% year-over-year to $0.93. It surpassed the consensus revenue estimates in all of the trailing four quarters.
The stock climbed 35.3% year-to-date and 9.6% over the past year to close the last trading session at $152.76.
ILMN's POWR Ratings reflect strong prospects. The stock has an overall rating of B, translating to a Buy in our proprietary rating system.
It has a B grade for Growth, Sentiment, and Quality. It is ranked #32 out of 328 stocks in the <a href="https://stocknews.com/category/biotech/">Biotech</a> industry.
To access ILMN's Stability, Momentum, and Value ratings, click <a href="https://stocknews.com/stock/ILMN/ratings/">here</a>.
Teladoc Health, Inc. (<a href="https://stocknews.com/stock/TDOC/">TDOC</a>)
Teladoc Health, Inc. delivers comprehensive virtual healthcare services globally through its Teladoc Health Integrated Care and BetterHelp segments. It offers a wide range of virtual medical services, chronic condition management, and mental health support, including online counseling via its Teladoc, Livongo, and BetterHelp brands.
TDOC's revenue was $640.51 million in the third quarter, which ended on September 30, 2024. The non-GAAP gross margin was 71.9%, and the cash flow from operations improved 4.4% from the year-ago value to $110.20 million.
Street expects TDOC's revenue to amount to $2.57 billion in the fiscal year ending December 2024. It surpassed the consensus EPS estimates in each of the trailing four quarters.
TDOC's bright prospects are apparent in its POWR Ratings. It has a B grade for Value. Within the <a href="https://stocknews.com/category/medical-services/">Medical - Services</a> industry, it is ranked #35 out of 62 stocks.
Click <a href="https://stocknews.com/stock/ISRG/ratings/">here</a> to see TDOC's ratings for Growth, Stability, Sentiment, Momentum, and Quality.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
ISRG shares were trading at $516.49 per share on Tuesday afternoon, up $9.07 (+1.79%). Year-to-date, ISRG has gained 53.10%, versus a 22.17% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Kritika Sarmah</h2> <img src='https:/wp-content/uploads/2022/08/Kritika-Sarmah_Image-3.jpg' style="float:left; padding:5px;width:125px;">Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist. She earned her bachelor's degree in commerce and is currently pursuing the CFA program. With her fundamental approach, she aims to help investors identify untapped investment opportunities.<a href="https://stocknews.com/authors/?author=kritika-sarmah">More...</a>The post <a href=https://stocknews.com/news/isrg-ilmn-tdoc-3-healthcare-stocks-innovating-with-ai/>3 Healthcare Stocks Innovating with AI</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Healthcare Stocks Innovating with AI

Tracking Baillie Gifford's 13F Portfolio - Q3 2024 Update

In today's tech-driven world, automation and AI innovations are shaping the future of manufacturing by boosting productivity, efficiency, and quality, addressing labor shortages, optimizing supply chains, and creating robust investment opportunities. Therefore, it may be wise to consider fundamentally strong automation stocks like Intuitive Surgical (ISRG), Honeywell International (HON), and Rockwell Automation (ROK). Read on... Automation has become essential in today's economy, driving productivity, efficiency, and quality while helping businesses navigate economic challenges. AI-driven solutions like autonomous robots and machine learning are streamlining processes, reducing costs, boosting quality, and reshaping manufacturing.
To capitalize on this trend, investors might consider top automation stocks like Intuitive Surgical, Inc. (<a href="https://stocknews.com/stock/ISRG/">ISRG</a>), Honeywell International Inc. (<a href="https://stocknews.com/stock/HON/">HON</a>), and Rockwell Automation, Inc. (<a href="https://stocknews.com/stock/ROK/">ROK</a>), which are leading the future of manufacturing.
Automation is transforming healthcare, aerospace, and manufacturing with advancements in building systems, sustainable energy, and digital solutions. By addressing labor shortages and enabling employees to focus on higher-skilled roles, automation reduces reliance on a shrinking workforce, making it a promising investment opportunity now and for the future.
The global automation-as-a-service market, valued at $2.04 billion in 2024, is projected to reach <a href="https://www.precedenceresearch.com/automation-as-a-service-market#:~:text=The%20global%20automation%20as%20a%20service%20market%20size%20is%20worth,forecast%20period%202024%20to%202034.">$13.45 billion by 2034</a>, growing at a 20.75% CAGR. This growth highlights innovations in healthcare for enhanced patient experiences, cost reductions, and accurate diagnoses, as well as advancements in industrial robotics to boost efficiency, reduce labor demands, and improve worker safety.
Furthermore, with the Industry 4.0 automation revolution, manufacturing is poised for gains in efficiency, productivity, faster time-to-market, cost savings, improved decision-making, and optimized supply chains. Reflecting this potential, the industrial machinery market is expected to grow at a <a href="https://www.gminsights.com/industry-analysis/industrial-machinery-market">7.5% CAGR</a> from 2024 to 2032.
Considering these trends, let's assess the fundamentals of the abovementioned automation stocks.
Intuitive Surgical, Inc. (<a href="https://stocknews.com/stock/ISRG/">ISRG</a>)
ISRG develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care internationally. The company offers the da Vinci Surgical System and the Ion endoluminal system.
In terms of the trailing-12-month <a href="https://www.investopedia.com/terms/l/levered-free-cash-flow.asp">levered FCF</a> margin, ISRG's 8.10% is 277.3% higher than the 2.15% industry average. Likewise, its 15.69% trailing-12-month Capex / Sales is 386.5% higher than the 3.23% industry average. Moreover, its 26.24% trailing-12-month EBIT margin is significantly higher than the 2.29% industry average.
ISRG's total revenues for the third quarter ended September 30, 2024, increased by 17% year-over-year to $2.04 billion. Its non-GAAP net income attributable to ISRG was $669.10 million, or $1.84 per share, up 27.7% and 26% from the prior-year quarter, respectively. Additionally, the company's non-GAAP income from operations increased slightly year-over-year to $754.90 million.
Street expects ISRG's EPS and revenue for the quarter ending December 31, 2024, to increase 9.5% and 14.1% year-over-year to $1.75 and $2.20 billion, respectively. It surpassed the Street EPS estimates in each of the trailing four quarters. The stock has gained 88.1% over the past year to close the last trading session at $524.28.
ISRG's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect strong fundamentals. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
It is ranked #79 out of 138 stocks in the <a href="https://stocknews.com/category/medical-devices-equipment/">Medical - Devices &amp; Equipment</a> industry. It has an A grade for Sentiment. To see ISRG's Growth, Value, Momentum, Stability, and Quality ratings, <a href="https://stocknews.com/stock/ISRG/">click here</a>.
Honeywell International Inc. (<a href="https://stocknews.com/stock/HON/">HON</a>)
HON engages in aerospace technologies, building automation, energy and sustainable solutions, and industrial automation businesses internationally. It operates in the Aerospace segment, Honeywell Building Technologies segment, Performance Materials and Technologies segment, and Safety and Productivity Solutions segment.
In terms of the trailing-12-month EBIT margin, HON's 20.89% is 104.3% higher than the 10.23% industry average. Similarly, its 7.73% trailing-12-month Return on Total Assets is 46.9% higher than the 5.26% industry average. Moreover, its 10.07% trailing-12-month levered FCF margin is 54.5% higher than the 6.52% industry average.
In the third quarter ended September 30, 2024, HON's net sales increased 8.5% year-over-year to $9.73 billion. Likewise, its segment profit grew 5.8% from the year-ago value to $2.30 billion. HON's adjusted EPS was $2.58, an increase of 8.4% from the prior-year period. Additionally, the company's free cash flow amounted to $1.72 billion, up 10.1% year-over-year.
For the quarter ending December 31, 2024, HON's EPS and revenue are expected to increase 7% and 8.5% year-over-year to $2.78 and $10.24 billion, respectively. HON surpassed consensus EPS estimates in each of the trailing four quarters. Over the past year, the stock has gained 16.6% to close the last trading session at $217.50.
HON's positive outlook is reflected in its POWR Ratings. It has an overall rating of B, equating to a Buy in our proprietary rating system.
HON has a B grade for Momentum and Stability. It is ranked #24 out of 79 stocks in the A-rated <a href="https://stocknews.com/category/industrial-machinery/">Industrial - Machinery</a> industry. <a href="https://stocknews.com/stock/HON/">Click here</a> to access additional ratings of HON for Growth, Value, Sentiment, and Quality.
Rockwell Automation, Inc. (<a href="https://stocknews.com/stock/ROK/">ROK</a>)
ROK provides industrial automation and digital transformation solutions across North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company operates through three segments: Intelligent Devices, Software &amp; Control, and Lifecycle Services. Its solutions include hardware, software products, and services.
On October 29, 2024, ROK announced the FactoryTalk DataMosaix App Builder, a low/no-code tool for creating industrial data visualizations and dashboards, integrated with FactoryTalk DataMosaix for seamless data management across cloud and on-premise platforms. This solution simplifies data access and reporting for enhanced productivity.
On October 15, 2024, ROK announced advancements to its FactoryTalk Optix portfolio with DataReady smart machines, enhancing real-time insights, seamless data transfer, and edge-to-cloud analytics for improved operational efficiency. This update empowers users with advanced visualization, HMI, and data exchange capabilities across various industrial applications.
In terms of the trailing-12-month gross profit margin, ROK's 39.83% is 25.5% higher than the 31.73% industry average. Its 20.40% trailing-12-month EBITDA margin is 46.4% higher than the 13.94% industry average. Likewise, the stock's 17.07% trailing-12-month EBIT margin is 66.9% higher than the 10.23% industry average.
ROK's total sales for the third quarter ended September 30, 2024, were $2.04 billion. The company's gross profit stood at $770.60 million. In addition, its adjusted net income and adjusted EPS were $281.90 million and $2.47, respectively.
Analysts expect ROK's EPS and revenue for the quarter ending June 30, 2025, to increase 2.9% and 4.7% year-over-year to $2.79 and $2.15 billion, respectively. It surpassed the Street EPS estimates in three of the trailing four quarters. Over the past three months, ROK's stock has gained 11.2% to close the last trading session at $277.09.
ROK's POWR Ratings reflect robust prospects. It is ranked #58 in the Industrial – Machinery industry. It has a B grade for Momentum and Quality. <a href="https://stocknews.com/stock/ROK/">Click here</a> to see ROK's Growth, Value, Stability, and Sentiment ratings.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
ISRG shares were unchanged in after-hours trading Friday. Year-to-date, ISRG has gained 59.01%, versus a 27.04% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Abhishek Bhuyan</h2> <img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;">Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.<a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a>The post <a href=https://stocknews.com/news/isrg-hon-rok-3-automation-stocks-driving-the-future-of-manufacturing/>3 Automation Stocks Driving the Future of Manufacturing</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Automation Stocks Driving the Future of Manufacturing

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Intuitive Surgical (ISRG – Research Report). Th...

Intuitive Surgical (ISRG) Gets a Buy from Bank of America Securities

Tracking Jeremy Grantham's GMO Capital Portfolio - Q3 2024 Update

Intuitive Surgical: One Of The Best Business Models In The World, But Not At This Price

BlackRock Global Equity Market Neutral Fund Q3 2024 Commentary

AGNG

ALNY

AMZN

ARKG

BMED

CACI

CARR

CNCR

CPNG

DASH

DXCM

EDOC

ESTC

FHLC

FTXH

GEHC

GNOM

GOOG

GOOGL

HART

HELX

HTEC

IBBQ

IDNA

IDXX

ILMN

IRBT

LABU

LRCX

MDEV

MELI

MRNA

PILL

PINK

PSCH

QLTY

RACE

RSPH

RYAAY

RYAOF

SBIO

SHOP

SPOT

TDOC

TOELF

TSLA

UTHR

VEEV

WDAY

WDNA

WFCNP

Press Releases

Sonder Capital Appoints Kate Garrett as Managing Partner to Lead Next Generation of Growth

Intuitive Announces First Quarter Earnings

Management

Intuitive Announces Board of Directors Elections and Retirements

Health Care

Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy

Intuitive Announces Second Quarter Earnings

Intuitive President David J. Rosa Appointed to Intuitive Board of Directors

Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular

Jupiter Endovascular Exits Stealth With $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism

Comments

Intuitive Surgical

ニュース

最新ニュース Intuitive Surgical (NASDAQ:ISRG) 株価情報

金曜日, 4 19, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル